Results 11 to 20 of about 683,800 (267)

Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer

open access: yesCells, 2020
The concept of immunogenic cell death (ICD) has emerged as a cornerstone of therapy-induced anti-tumor immunity. To this end, the following chemotherapies were evaluated for their ability to induce ICD in non-small cell lung cancer (NSCLC) cell lines ...
Tal Flieswasser   +9 more
doaj   +1 more source

Integrating patient-reported physical, mental, and social impacts to classify long COVID experiences

open access: yesScientific Reports, 2023
Long COVID was originally identified through patient-reported experiences of prolonged symptoms. Many studies have begun to describe long COVID; however, this work typically focuses on medical records, instead of patient experiences, and lacks a ...
Keri Vartanian   +5 more
doaj   +1 more source

The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies

open access: yesFrontiers in Immunology, 2021
Cetuximab has an established role in the treatment of patients with recurrent/metastatic colorectal cancer and head and neck squamous cell cancer (HNSCC).
Hasan Baysal   +9 more
doaj   +1 more source

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma

open access: yesBiomedicines, 2022
Malignant pleural mesothelioma (MPM) is a fatal cancer type that affects the membranes lining the lungs, and is causally associated with asbestos exposure. Until recently, the first-line treatment consisted of a combination of chemotherapeutics that only
Sophie Rovers   +6 more
doaj   +1 more source

Sublinear domination and core–periphery networks [PDF]

open access: yesScientific Reports, 2021
AbstractIn this paper we devise a generative random network model with core–periphery properties whose core nodes act as sublinear dominators, that is, if the network has n nodes, the core has size o(n) and dominates the entire network. We show that instances generated by this model exhibit power law degree distributions, and incorporates small-world ...
openaire   +4 more sources

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers

open access: yesAntioxidants, 2023
Auranofin (AF) is a potent, off-patent thioredoxin reductase (TrxR) inhibitor that efficiently targets cancer via reactive oxygen species (ROS)- and DNA damage-mediated cell death.
Laurie Freire Boullosa   +11 more
doaj   +1 more source

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model

open access: yesPharmaceutics, 2022
The antineoplastic activity of the thioredoxin reductase 1 (TrxR) inhibitor, auranofin (AF), has already been investigated in various cancer mouse models as a single drug, or in combination with other molecules.
Laurie Freire Boullosa   +11 more
doaj   +1 more source

Emergence of core–peripheries in networks [PDF]

open access: yesNature Communications, 2016
AbstractA number of important transport networks, such as the airline and trade networks of the world, exhibit a characteristic core–periphery structure, wherein a few nodes are highly interconnected and the rest of the network frays into a tree. Mechanisms underlying the emergence of core–peripheries, however, remain elusive. Here, we demonstrate that
Verma, T.   +4 more
openaire   +6 more sources

Research and Development of Delay-Sensitive Routing Tensor Model in IoT Core Networks

open access: yesSensors, 2021
In the article, we present the research and development of an improved delay-sensitive routing tensor model for the core of the IoT network. The flow-based tensor model is considered within the coordinate system of interpolar paths and internal node ...
Oleksandr Lemeshko   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy